IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#4503
Positioning
Market Dominance
Services
Computer Software
$0
Ann M. Sastry
Amesite Inc., an artificial intelligence driven platform and course designer, provides online products in the U.S. The company uses machine learning to offer a mass customized experience to learners. The company was incorporated in 2017 and is headquartered in Detroit, Michigan.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = AMST ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$YALA Yalla Group Ltd | 75 | 89 | 99 | 80 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$GRVY GRAVITY Co., Ltd. | 75 | 82 | 96 | 71 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC | 73 | 81 | 88 | 94 | 25.0x | 14.1x | 17.1% | 10.3% | 35.5% | 14.6% | 10.1% | 105.2% | 0.0% | 41.0x | $244M | VS | |
$AER AerCap Holdings N.V. | 72 | 60 | 87 | 84 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$HCSG HEALTHCARE SERVICES GROUP INC | 72 | 74 | 88 | 88 | 7.1x | 6.1x | 28.9% | 20.8% | 20.8% | 9.9% | 9.3% | 8.5% | 0.0% | 1.0x | $1.2B | VS | |
$LQDT LIQUIDITY SERVICES INC | 72 | 90 | 88 | 68 | 24.9x | 14.3x | 14.1% | 8.3% | 45.7% | 8.5% | 6.2% | 28.1% | 0.0% | 0.0x | $736M | VS | |
$TRTNpA Triton International Ltd | 71 | 70 | 89 | 70 | - | 1.7x | 0.0% | - | 97.4% | 58.0% | 37.4% | - | 8.8% | 264.0x | $2.5B | VS | |
$EDU New Oriental Education & Technology Group Inc. | 71 | 83 | 52 | 77 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$NTES NetEase, Inc. | 71 | 88 | 93 | 68 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$UTI UNIVERSAL TECHNICAL INSTITUTE INC | 70 | 86 | 86 | 72 | 43.2x | 16.0x | 15.3% | 5.8% | 100.0% | 6.9% | 5.2% | 15.1% | 0.0% | 24.0x | $1.8B | VS | |
$AMST Amesite Inc. | 30 | 25 | 25 | 27 | - | - | -209.5% | -158.1% | 100.0% | -3123.8% | -3077.8% | 860.4% | 0.0% | 32.0x | $0 | ||
| SECTOR BENCH | - | - | - | - | - | 23.7x | 11.7x | 5.7% | 2.4% | 64.6% | 4.5% | 2.8% | 8.6% | 0.0% | 0.3x | - | REF |
Amesite Inc. (AMST) receives a "Avoid" rating with a composite score of 30.4/100. It ranks #4503 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
Lagging peers — losers tend to keep underperforming
Expensive relative to fundamentals — limited margin of safety
Weak fundamentals — higher risk of value trap
Average volatility — neutral timing signal
Aggressive spending — empire-building risk, dilutive growth
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Services sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for AMST.
View All Ratings| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 25 | 9 | +16ALPHA |
| MOMENTUM | 27 | 21 | +6ALPHA |
| VALUATION | 25 | 16 | +9ALPHA |
| INVESTMENT | 21 | 5 | +16ALPHA |
| STABILITY | 46 | 45 | +1NEUTRAL |
| SHORT INT | 37 | 29 | +8ALPHA |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy -209.5% (sector 5.7%)
GM 100% vs sector 65%, OM -3124% vs sector 5%
Capital turnover N/A, R&D intensity 132.3%
Rev growth 860%, 6yr history
Interest coverage N/A
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate Amesite Inc. (AMST) as Avoid with a composite score of 30.4/100 at a current price of $1.80. The stock falls in the bottom quintile, and the multi-factor weakness suggests a high probability of continued underperformance.
Amesite Inc. holds a top-quartile position (#0 of 50) within the Services sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 30.4/100 places it at rank #4503 in our full universe.
Narrow
High
Poor
Fair Value
Gross margins of 100% signal strong pricing power.
Stable competitive position in a defensive sector.
Weak momentum suggests persistent institutional selling pressure.
Below-average quality raises earnings sustainability concerns.
Vulnerability to macroeconomic shocks and interest rate volatility.
Amesite Inc. represents a avoid based on multi-factor quantitative performance.
Our quantitative model flags Amesite Inc. with an Avoid rating, assigning a composite score of 30.4/100 and 1 out of 5 stars. Ranked #4503 of 7,333 stocks, AMST falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
AMST's quality score of 25/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of -209.5% (sector avg: 5.7%), gross margins of 100.0% (sector avg: 64.6%), net margins of -3077.8% (sector avg: 2.8%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
AMST registers a value score of just 25/100, suggesting the stock trades at a significant premium to its fundamental metrics. Key valuation metrics include a P/B ratio of 5.46x. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
Amesite Inc.'s investment score of 21/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 860.4% vs. a sector average of 8.6% and a return on assets of -158.1% (sector: 2.4%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
Amesite Inc. is experiencing notably weak momentum with a score of just 27/100. The stock has underperformed its peers and is trending below major moving averages. Revenue growth stands at 860.4% year-over-year, while a beta of 0.76 reflects its sensitivity to broader market moves. While deep momentum weakness can occasionally present value opportunities, it often reflects deteriorating fundamentals or structural headwinds that may persist.
With a stability score of 46/100, AMST exhibits average financial resilience. Key stability metrics include a beta of 0.76 and a debt-to-equity ratio of 32.00x (sector avg: 0.3x). While the balance sheet is not a major concern, the stock is subject to typical market volatility and may experience sharper drawdowns during risk-off episodes.
Amesite Inc.'s short interest score of 37/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. Specific risk factors include elevated leverage (D/E: 32.00x), micro-cap liquidity risk. At $0 (micro-cap), AMST carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
Amesite Inc. is a micro-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #4503 of 7,333 overall (39th percentile). Key comparisons include ROE of -209.5% trailing the 5.7% sector median and operating margins of -3123.8% below the 4.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.
While AMST currently exhibits a AVOID profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Services Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Investment (21) would have the largest impact on the composite score.
ROE 3750% BELOW SECTOR MEDIAN
Gross Margin 55% ABOVE SECTOR MEDIAN (FAVORABLE)
Op. Margin 69519% BELOW SECTOR MEDIAN
Above 50MA
37.18%
Net New Highs
+51081
Amesite Inc. announced a 63% revenue growth for its NurseMagic™ platform following the launch of its Enterprise subscription model. The company also introduced AI-powered government form-fill automation, which aims to reduce the reporting burden for post-acute care providers, especially in light of upcoming CMS mandates like the HOPE assessment. This move positions NurseMagic™ Enterprise as a competitive solution for organizations seeking to scale operations and ensure full reimbursements without increasing staff.
Amesite Inc. (AMST) saw significant revenue growth year-over-year after pivoting to healthcare solutions and launching the NurseMagic™ app. However, the company continues to experience losses, raising substantial doubt about its ability to continue as a going concern, and still faces Nasdaq compliance risks and a need for additional financing. This information is based on their SEC 10-Q Quarterly Report from February 6, 2026.
Amesite Inc. (NASDAQ:AMST) has launched NurseMagic EMR, an AI-native electronic medical record system, to enter the growing post-acute care market. The company projects significant revenue growth for fiscal 2026, driven by an aging population and a shift towards home-based care. NurseMagic EMR is designed to either integrate with existing systems or completely replace them, offering flexibility to post-acute providers.
Amesite Inc. has launched NurseMagic™ EMR, an AI-native electronic medical record system, significantly expanding its AI solutions into the post-acute care market. This modular system can either integrate with existing EMRs or fully replace them, offering unprecedented flexibility for healthcare providers. The launch follows a year of strong revenue growth for Amesite, driven by the introduction of higher-tier products like Teams+ and Enterprise, and positions the company for further penetration into the growing U.S. post-acute care sector.
Amesite (NASDAQ: AMST) has launched its AI-native NurseMagic EMR, expanding its platform into core post-acute care infrastructure. The company plans to begin onboarding EMR customers in January 2026, targeting a U.S. post-acute care market valued at over $470 billion. This launch follows significant revenue growth for Amesite, with quarterly increases of 2.4x, 82%, and 69% linked to the rollout of higher-value product tiers.